PCN64 Evaluating the Cost-Effectiveness of the Addition of Rituximab to Chemotherapy in the First Line Treatment of Follicular Lymphoma Patients in the UK
Abstract
Authors
R. Rafia D. Papaioannou M. Stevenson J. Rathbone H.B. Woods